Core Laboratories Inc.
NLFinancials
Valuation Metrics
Core Laboratories Inc.'s Market Cap is $495M. At end of 2025 it was $745M. Ranked #2805 of 3,111 in US market (top 90%), #1582 of 1,666 on NYSE (top 95%), #167 of 174 in Energy (top 96%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $495M | US#2,805/3,111 Sec#167/174 |
| Revenue | $519M | US#2,329/3,111 Sec#145/174 |
| Net Income | $24M | US#2,013/3,111 Sec#123/174 |
| Total Assets | $587M | US#2,695/3,111 Sec#167/174 |
| Net Assets | $279M | US#2,617/3,111 Sec#160/174 |
| Value | ||
| P/E | 20.31x | US#819/3,111 Sec#62/174 |
| P/B | 1.77x | US#1,098/3,111 Sec#74/174 |
| P/S | 0.95x | US#631/3,111 Sec#38/174 |
| EV/EBITDA | 8.16x | US#594/3,111 Sec#84/174 |
| FCF Yield | 4.36% | US#1,567/3,111 Sec#107/174 |
| Profitability | ||
| ROE | 8.74% | US#1,269/3,111 Sec#90/174 |
| ROA | 4.15% | US#1,009/3,111 Sec#70/174 |
| Op. Margin | 9.25% | US#1,612/3,111 Sec#108/174 |
| Revenue Growth | -4.26% | US#2,353/3,111 Sec#124/174 |
| Earnings Growth | -44.00% | US#1,482/3,111 Sec#69/174 |
| Financial Health | ||
| Debt Ratio | 110.49% | US#1,227/3,111 Sec#80/174 |
| Total Debt | $39M | US#2,279/3,111 Sec#152/174 |
| FCF | $22M | US#2,154/3,111 Sec#131/174 |
| Cash | $23M | US#2,850/3,111 Sec#150/174 |
| Current Ratio | 2.12x | US#1,228/3,111 Sec#40/174 |
| Net Debt/EBITDA | 0.26x | US#1,353/3,111 Sec#96/174 |
| Dividend | ||
| Div. Yield | 0.28% | US#1,563/3,111 Sec#125/174 |
| Div. Growth | 0.50% | US#1,181/3,111 Sec#74/174 |
| Payout Ratio | 5.88% | US#2/3,111 Sec#1/174 |
| Performance | ||
| 1Y Return | 1.90% | US#2,105/3,111 Sec#145/174 |
| 1M Return | -6.37% | US#2,359/3,111 Sec#154/174 |
| From 52W High | -47.30% | US#2,688/3,111 Sec#163/174 |
| 1Y MDD | -49.82% | US#2,397/3,111 Sec#159/174 |
| Trading | ||
| Volume | 505,911 shares | US#1,843/3,111 Sec#117/174 |
| Trading Value | $5M | US#2,490/3,111 Sec#144/174 |
| Per Share | ||
| EPS | $0.68 | US#1,762/3,111 Sec#113/174 |
| BPS | $5.99 | US#2,133/3,111 Sec#132/174 |
Company Info
Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.